Skip to main content
. 2022 Sep 19;13:991879. doi: 10.3389/fphar.2022.991879

FIGURE 4.

FIGURE 4

Metabolic differences between responders and non-responders to anti-VEGF treatment in nAMD and PCV, respectively. (A) Principal component analysis (PCA) model showed significant difference in nAMD. (B) Partial least squares discriminant analysis (PLS-DA) model showed significant difference in nAMD. (C) PCA model showed significant difference in PCV. (D) PLS-DA model showed significant difference in PCV.